The induction of liver tumors by 239Pu citrate or 239PuO2 particles in the Chinese hamster.

The influence of radiation dose distribution on the frequency of 239Pu-induced liver tumors was evaluated in the Chinese hamster. Different concentrations of 239Pu citrate 239PuO2 particles of known sizes were injected intravenously via the jugular vein. About 60% of the injected 239Pu citrate was deposited in the liver and 40% in the bone. The 239Pu citrate was rather uniformly distributed throughout the liver parenchyma. Injected plutonium oxide particles were taken up by the reticuloendothelial system with 90% of the body burden deposited in the liver. The 239PuO2 particles were localized in the Kupffer cells and produced nonuniform dose distributions that were dependent on particle size. There was an activity- and dose-dependent increase in the incidence of total liver parenchymal cell tumors following injection with either plutonium particles or citrate. For animals that received 14.0-, 2.7-, 0.3-, and 0.04-Gy dose to liver from 239Pu citrate the cumulative tumor incidence was 39, 32, 5, and 0%, respectively. Animals that were injected with the 0.24 micron 239PuO2 particles had doses of 42.0, 7.2, and 0.8 Gy to the liver and tumor incidences of 34, 26, and 5%, respectively. Plutonium citrate also produced hemangiosarcomas of the liver and tumors in bone and bone marrow. The latent period for liver tumor appearance in animals exposed to 239Pu citrate or 239PuO2 particles increased as the injected activity decreased. For animals injected with a similar total activity (7.4 Bq/g), the lifetime cumulative liver tumor incidence was similar for animals exposed to either 239Pu citrate (32%) or 239PuO2 (26%). There was little effect of particle size on liver tumor incidence. These data indicate that, in Chinese hamster liver, local radiation dose distribution is less important in altering tumor incidence than injected activity or average dose. However, the more uniform irradiation from 239Pu citrate administration was more effective in cancer production than the nonuniform irradiation from 239PuO2 particles.

[1]  T. Maruyama,et al.  Epidemiological follow-up study of Japanese thorotrast cases. , 1979, Environmental research.

[2]  R. McClellan,et al.  The influence of testicular microanatomy on the potential genetic dose from internally deposited 239Pu citrate in Chinese hamster, mouse, and man. , 1979, Radiation research.

[3]  M. Tavares,et al.  Malignancies in Portuguese thorotrast patients. , 1978, Health physics.

[4]  A. Brooks Chromosome damage in liver cells from low dose rate alpha, beta, and gamma irradiation: derivation of RBE , 1975, Science.

[5]  P. Kotrappa,et al.  Design and Performance of the Lovelace Aerosol Particle Separator , 1972 .

[6]  P. Kotrappa,et al.  Technology for the production of monodisperse aerosols of oxides of transuranic elements for inhalation experiments. , 1972, Health physics.

[7]  C. Richmond,et al.  Biological response to small discrete highly radioactive sources. II. Morphogenesis of microlesions in rat lungs from intravenously injected 238 PuO 2 microspheres. , 1970, Health physics.

[8]  G. Powers,et al.  Determination of plutonium in biological materials by extraction and liquid scintillation counting. , 1970, Analytical chemistry.

[9]  R. Albert,et al.  The RBE for skin tumors and hair follicle damage in the rat following irradiation with alpha particles and electrons. , 1968, Radiation research.

[10]  F. Ederer,et al.  Maximum utilization of the life table method in analyzing survival. , 1958, Journal of chronic diseases.